The Cologne Cluster of Excellence on Cellular stress responses in Aging-associated Diseases – short CECAD – is a DFG-funded Cluster of Excellence dedicated to unravelling the underlying mechanisms of aging and aging-associated diseases. Aging is a lifelong process and root for a range of chronic diseases such as cancer, diabetes, cardiovascular diseases, renal failure, and neurodegenerative disorders. With the increasing life expectancy in societies, aging-associated diseases pose a major societal challenge with a far-reaching economic impact. CECAD addresses that challenge by exploring the molecular basis of the aging process and developing new therapeutic concepts for aging-associated diseases. With more than 400 basic and clinician scientists working at the University of Cologne, the Cologne University Hospital, the Max Planck Institutes for Metabolism Research and Biology of Ageing, and the German Center for Neurodegenerative Diseases (DZNE), CECAD is one of the largest academic centers for aging research in Europe.
CECAD is devoted to biomedical aging research, training young scientists for the challenges of the aging society, and translating discoveries into clinical practice. The Cologne Graduate School on Aging is training PhD students from 22 countries. CECAD’s translational platform follows the bench to bedside and back approach to derive therapies from discovery science and address new clinical challenges by basic research. CECAD hosts a wide range of cutting edge technological platforms including imaging, genomics & bioinformatics, proteomics, lipidomics, metabolomics and in vivo research.
CECAD is devoted to promote researchers at all stages of their career from training undergraduate and graduate students, to mentoring postdocs and group leaders. Our scientific community is particularly aiming to advance diversity and support the careers of female scientists at all levels and generate an inclusive and family friendly work environment.
Company Details
- Employees
- 195
- Founded
- -
- Address
- Joseph-Stelzmann Straße 26, Köln,nordrhein-Westfalen 50931,germany
- Industry
- Research
- Keywords
- molecular research, basic research, translational research, imaging, proteomic, bioinformatics, lipidomics, metabolomics, aging-associated diseases, diabetes, cancer, Alzheimer's, Parkinson's.
- HQ
- Köln, Nordrhein-Westfalen
- Competitors
- Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Center for Molecular Medicine Cologne (CMMC), German Center for Neurodegenerative Diseases (DZNE), Uniklinik Köln, Cluster of Excellence ImmunoSensation - University of Bonn, Max Planck Institute for Metabolism Research, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Institute for Biology of Ageing, Cologne Graduate School of Ageing Research, ML4Q | Matter and Light for Quantum Computing.
Cecad Cologne Questions
Cecad Cologne's website is https://www.cecad.uni-koeln.de/home/
Cecad Cologne's LinkedIn profile is https://de.linkedin.com/company/cecad-cologne
Cecad Cologne has
195 employees.
View email and phone details for 195
employees at Cecad Cologne.
Cecad Cologne's industry is
Research
Cecad Cologne's top competitors are
Leibniz Institute On Aging - Fritz Lipmann Institute (Fli),
Center For Molecular Medicine Cologne (Cmmc),
German Center For Neurodegenerative Diseases (Dzne),
Uniklinik Köln,
Cluster Of Excellence Immunosensation - University Of Bonn,
Max Planck Institute For Metabolism Research,
Max Planck Institute Of Immunobiology And Epigenetics,
Max Planck Institute For Biology Of Ageing,
Cologne Graduate School Of Ageing Research,
Ml4q | Matter And Light For Quantum Computing.
Cecad Cologne's categories are Research
Cecad Cologne's founding year is 2007
